Literature DB >> 16033684

Steroid-free immunosuppression in organ transplantation.

Gaoxing Luo1, Edward M Falta, Eric A Elster.   

Abstract

Although steroids have been the cornerstone of immunosuppressive regimens to treat and prevent rejection in organ transplantation, the past decade has seen many successful attempts to minimize or eliminate steroid use. This has been undertaken to decrease the diverse side effects seen with chronic steroid treatment. These efforts have focused on both steroid avoidance and complete elimination, and have been successful across broad patient groups. The key to these efforts has been the adoption of induction protocols with either lymphocyte-depleting agents or anti-interleukin-2 strategies, coupled with the use of the newer maintenance immunosuppressants. In this review, we address the feasibility and benefits of steroid-free and steroid avoidance protocols in kidney, pancreas, liver, and heart transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033684     DOI: 10.1007/s11892-005-0028-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  45 in total

1.  Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy.

Authors:  S John Swanson; Douglas A Hale; Roslyn B Mannon; David E Kleiner; Linda C Cendales; Christine E Chamberlain; Shirley M Polly; David M Harlan; Allan D Kirk
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

2.  Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience.

Authors:  M R Pritzker; K D Lake; T J Reutzel; F M Hoffman; C R Jorgensen; W Pederson; R W Emery
Journal:  J Heart Lung Transplant       Date:  1992 Mar-Apr       Impact factor: 10.247

3.  FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

Authors:  T Kino; H Hatanaka; S Miyata; N Inamura; M Nishiyama; T Yajima; T Goto; M Okuhara; M Kohsaka; H Aoki
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

Review 4.  Avoiding steroids in solid organ transplantation.

Authors:  Jan P Lerut
Journal:  Transpl Int       Date:  2003-04-02       Impact factor: 3.782

5.  Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol.

Authors:  S A Birkeland; H K Andersen; S J Hamilton-Dutoit
Journal:  Transplantation       Date:  1999-05-15       Impact factor: 4.939

6.  Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.

Authors:  James D Eason; Satheesh Nair; Ari J Cohen; Jamie L Blazek; George E Loss
Journal:  Transplantation       Date:  2003-04-27       Impact factor: 4.939

7.  Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.

Authors:  C E Freise; S M Kang; S Feng; A Posselt; K Hirose; R Hirose; P Stock
Journal:  Transplant Proc       Date:  2004-05       Impact factor: 1.066

Review 8.  Immunosuppression for long-term maintenance of renal allograft function.

Authors:  Gerd Offermann
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Break of tolerance via donor-specific blood transfusion by high doses of steroids: a differential effect after intestinal transplantation and heart transplantation.

Authors:  T Koshiba; H Kitade; M Waer; C Mathieu; B Van Damme; J Pirenne
Journal:  Transplant Proc       Date:  2003-12       Impact factor: 1.066

10.  Psychiatric outcome of heart transplantation.

Authors:  P A Shapiro; D S Kornfeld
Journal:  Gen Hosp Psychiatry       Date:  1989-09       Impact factor: 3.238

View more
  1 in total

Review 1.  Induction therapy in pediatric renal transplant recipients: an overview.

Authors:  Asha Moudgil; Dechu Puliyanda
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.